Crinecerfont Hydrochloride

N/A

Report date: 2026/04/20 20:01:59
NME

Base Information

Drug NameCrinecerfont Hydrochloride
Drug Alias NameCrinecerfontCrenessitySSR-125543SSR-125543ANBI-74788
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsDepressive Disorder, MajorAdrenal Hyperplasia, Congenital
Global Approved IndicationsAdrenal Hyperplasia, Congenital
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/12/13
Country/TerritoryCzechiaBelgiumBulgaria +[24] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesSanofi
Active IndicationsAdrenal Hyperplasia, Congenital
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG